Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Small Pharma Inc
V.DMT
Healthcare
Small Pharma Inc. is a biotechnology company focused on short-duration psychedelic therapies for mental health conditions. The Company is focused on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions that are scalable, commercially differentiated, and conveniently dosed, with the goal of addressing key unmet needs in the treatment of...
depression. It has a portfolio of clinical-stage dimethyltryptamine (DMT)-based assets, SPL026 and SPL028. It has a pipeline of proprietary preclinical assets. Its clinical-stage program, SPL026, a first-generation DMT molecule, has shown proof-of-concept for the potential treatment of MDD. In a Phase IIa study, IV SPL026 demonstrated a rapid and durable antidepressant effect, as well as a favorable safety and tolerability profile. Small Pharma is also advancing SPL028, a second-generation injectable deuterated DMT molecule, in a Phase I trial.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:DMT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Post by
GillRipper
on Jan 25, 2023 9:40am
Positive Top Line Results
https://www.youtube.com/watch?v=ym-zzyOe1dA The management team will host a conference call at 8:30AM EST / 1:30PM GMT to discuss the top-line results. Click here to view webcast (to view
...more
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Post by
GillRipper
on Jan 25, 2023 9:34am
Fiscal Third Quarter 2023
25 January 2023 News Small Pharma Reports Fiscal Third Quarter 2023 Highlights – Positive
...more
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Post by
GillRipper
on Jan 24, 2023 7:03pm
Phase IIA Trial
24 January 2023 News Small Pharma to announce results of SPL026 Phase IIa trial for Major Depressive Disorder and host conference call on Wednesday, January 25
...more
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Post by
GillRipper
on Jan 16, 2023 6:54pm
Good to see the trials moving along.
And the vol and SP gradually pick up again. In for the long run. I own 200k at .16 Kind Regards To All Gilly Latest update Small Pharma doses first patient in SPL026 study
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 11, 2022 7:50am
New Press Release - Small Pharma to Participate in November Investor and Healthcare Conferences
LONDON, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announce its participation in the following upcoming...
read article.
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Comment by
GillRipper
on Oct 31, 2022 11:54am
RE: Small Pharma Receives Approval for First-In-Human Phase I C
Mainstream Med in 5 years methinks! Wonder who got placed with that block Rands sold last week, influencial(s)? Latest Presentation Wow....last at .17....Incredible! https://docsend.com/view
...more
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Post by
GillRipper
on Oct 31, 2022 9:32am
Small Pharma Receives Approval for First-In-Human Phase I C
SMALL PHARMA INC (C-DMT) - News Release ORIGINAL: Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028 2022-10-31 07:50 ET - News Release DMT Close
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 31, 2022 7:50am
New Press Release - Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028
SPL028 is the Company’s injectable deuterated DMT candidate with multi-layered IP protection The Phase I study aims to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of IM and IV administration of SPL028LONDON, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV...
read article.
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Comment by
GillRipper
on Oct 28, 2022 11:42am
RE:CEO Rands Bought The Block
Correction, SOLD the block. Kind Regards To All Gilly
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Post by
GillRipper
on Oct 28, 2022 11:40am
CEO Rands Bought The Block
Date Issuer Insider Transaction Amount New Balance Recent filings Filed 2022-10-28 07:36 Tx
...more
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Post by
GillRipper
on Oct 26, 2022 12:20pm
This Mornings Trading
Eight takes 1.5 million from Anon so far this morning. Kind Regards To All The Gipper
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Post by
GillRipper
on Oct 14, 2022 6:19pm
October Insider Filings
Date Issuer Insider Transaction Amount New Balance Filed 2022-10-06 08:49 Tx date 2022-10-05 $DMT
...more
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Post by
GillRipper
on Oct 14, 2022 6:15pm
Small Pharma has Aug. 31 cash position of $27.1-million
Small Pharma has Aug. 31 cash position of $27.1-million 2022-10-14 17:34 ET - News Release Mr. George Tziras reports SMALL PHARMA REPORTS FISCAL SECOND QUARTER 2023
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 19, 2022 7:30am
New Press Release - Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial in Patients With Major Depressive Disorder
Dosing for primary endpoint now complete LONDON, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that it...
read article.
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Comment by
GillRipper
on Sep 14, 2022 2:03pm
RE:Share Buy Back In Full Swing
As of 11:00 Am Company looks to be buying again theu 8 Kind Regards To All The Gipper House Positions for C:DMT from 20220914 to 20220914 House
...more
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments